The Clinical Efficacy and Safety of Iguratimod in RA and Early RA Patients for 6 Months Treatment
Clinical trial NCT03855007 · COMPLETED
Trial details
- NCT number
- NCT03855007
- Sponsor
- Qilu Hospital of Shandong University
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2023-09-30
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.